Price Reductions for Third Transitional Cycle

Summary of 1 August 2012 Price Reductions for Third Transitional Cycle by Drug / Manner of Administration / Weighted Average Percentage Reduction.

Drug

Manner of Administration

Weighted Average Percentage Reduction

Amisulpride

Oral

18.27%

Bisoprolol

Oral

18.75%

Cefalotin

Injection

16.99%

Doxorubicin

Injection/intravesical

32.97%

Escitalopram

Oral

36.76%

Levetiracetam

Oral

14.15%

Meloxicam

Oral

23.62%

Mitozantrone

Injection

18.25%

Ondansetron

Injection

77.25%

Oxaliplatin

Injection

51.76%

Oxybutynin

Oral

11.25%

Perindopril with Indapamide

Oral

11.59%

Prochlorperazine

Oral

25.55%

For further information about specific prices for pharmaceutical items please see the Federal Register of Legislative Instruments (FRLI): www.comlaw.gov.au/Details/F2012L00931